好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Motor Impairment in Multiple Sclerosis: Analysis from the North American Registry for Care and Research in Multiple Sclerosis (NARCRMS)
Multiple Sclerosis
MS and CNS Inflammatory Disease Posters (7:00 AM-5:00 PM)
033

To describe upper (9-hole peg test (9HPT)) and lower extremity (25-foot walk (25-FW)) function in participants at enrollment as a function of their disability (Extended disability status scale (EDSS))

Few studies have examined concurrent impairment of upper and lower extremity function in multiple sclerosis (MS).  The North American Registry for Care and Research in MS (NARCRMS) is a longitudinal registry studying the course of MS in the disease-modifying era and provided an opportunity to examine motor impairment in large numbers of patients.

Seven hundred and seventy-seven subjects were recruited as of October 16th, 2020.  Various clinical metrics were collected including motor performance for upper and lower extremities and EDSS scores.

EDSS and 25-FW times were available in 651, and 9-HPT in 647 subjects. Mean walking speed of 4.96 seconds was recorded in patients with EDSS of 0 and progressed to 18.09 seconds with aids by EDSS 6.5.  For the 9-HPT, patients with EDSS of 0 had a mean speed of 19.45 seconds in the dominant and 20.46 seconds in the non-dominant hand. Hand function remained unimpaired until EDSS of 2.0 and progressively worsened with worsening disability, and at EDSS 6.5 speed had declined to 38.43 seconds for the dominant and 50.88 seconds for the non-dominant hand.

A linear correlation of the 25-FW speed to EDSS increases reiterates the commonly held belief that EDSS is a “walking scale”. Decline in hand function at EDSS of 2.5 was unexpected since hands are often perceived to be unaffected early in MS and seldom observed as impaired by patients. Progressive decline of hand function at every EDSS increase, occurring concurrently with decline in lower extremity motor performance, suggests that the 9-HPT is a good marker of declining hand function and should be included in clinical monitoring of patients.

Authors/Disclosures
Kottil W. Rammohan, MD (University of Miami)
PRESENTER
Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
David K. Li, MD (University of British Columbia) Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
June Halper, RN, ANP (CMSC) Ms. Halper has nothing to disclose.
Sara McCurdy Murphy No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Seema R. Khurana Seema R. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pirmal.